Study Does Not Support Use Of Piperacillin-Tazobactam For Hard-To-Treat Bloodstream Infections.

September 12, 2018

Medscape (9/11, Harrison, Subscription Publication) reports a noninferiority MERINO trial indicates piperacillin-tazobactam, “a potentially ‘carbapenem-sparing’ option for the treatment of bloodstream infections caused by ceftriaxone-resistant Escherichi...